Imbing, Meliza Rose B.
HRN: 16-52-90 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2022
CEFUROXIME 1.5GM (VIAL)
04/26/2022
05/02/2022
IV
750mg
Q8
UTI
Waiting Final Action